Assessment of cardiac excitation-contraction coupling and effect of positive inctropic agent on Ca^<2+> regulating function of sarcoplasmic reticulum in heart failan

心衰患者心脏兴奋-收缩耦合及正性收缩剂对肌浆网Ca^2调节功能的影响

基本信息

  • 批准号:
    11670684
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

In tachycardia-induced heart failure (HF), LV function was assessed in parallel with the function of sarcoplasmic reticulum (SR) taken from LV muscle. First, in HF, positive inotropic effects of milrinone or dobutamine were decreased, whereas positive lusitropic effects were well preserved. The enhancement of the sensitivity of SR Ca^<2+>-ATPase on cyclic AMP was observed in HF, which might be involved in this preservation of positive lusitropy. Second, a prominent abnormal Ca^<2+> leak occurred through the Ca^<2+> release channel of the SR (ryanodine receptor ; RyR) in HF, in which the stoichiometry of FK binding protein per RyR was decreased. This partial loss of RyR-bound FKBP12.6 seems to induce an instability in the channel's properties through a protein conformational change. This leads to a prominent Ca^<2+> leak, which is a possible cause of Ca^<2+> overload and hence diastolic dysfunction, as well as of systolic dysfunction. Third, in HF the altered interaction between FKBP12.6 and RyR induced an instability of RyR-channel properties and a resulting impairment of the Ca^<2+>-release function of RyR.
在心动过速引起的心力衰竭(HF)中,左室功能与取自左室肌肉的肌浆网(SR)功能同时进行评估。首先,在心力衰竭中,米力农或多巴酚丁胺的正性肌力作用减弱,而正性舒张作用则得到很好的保留。在HF中观察到SR Ca ^ 2+ -ATP酶对环AMP的敏感性增强,这可能与正向松弛性的保留有关。其次,HF中SR(兰尼碱受体;RyR)的Ca ^ 2+ 释放通道发生显着的异常Ca ^ 2+ 泄漏,其中每个RyR的FK结合蛋白的化学计量减少。 RyR 结合的 FKBP12.6 的部分丢失似乎通过蛋白质构象变化导致通道特性的不稳定。这导致显着的Ca ^ 2+ 泄漏,这是Ca ^ 2+ 过载并因此导致舒张功能障碍以及收缩功能障碍的可能原因。第三,在HF中,FKBP12.6和RyR之间相互作用的改变引起了RyR通道性质的不稳定,并导致RyR的Ca ^ 2+ -释放功能受损。

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Taketo Tanigawa: "The mechanism of preserved positive lusitropy by cyclic AMP-dependent drugs in heart failure"American Journal of Physiology. 278. H313-H320 (2000)
Taketo Tanikawa:“环AMP依赖性药物在心力衰竭中保留正向松弛性的机制”美国生理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masafumi Yano: "Abnormal sarcoplasmic reticulum Ca2+ release in heart failure"Cardiovasc Res. 45. 1070-1071 (2000)
Masafumi Yano:“心力衰竭中肌浆网 Ca2 释放异常”Cardiovasc Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Taketo Tanigawa: "The mechanism of preserved nositive lusitropy by cyclicAMP-dependent drugs in heart failure."Am J Physiol. 278. H313-H320 (2000)
Taketo Tanikawa:“环AMP依赖性药物在心力衰竭中保留鼻窦松弛的机制。”Am J Physiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Taketo Tanigawa et al: "Mechanism of preserved positive lusitropy by cAMP-dependent drugs in heart failure"American Journal of Physiology. 278. H313-H320 (2000)
Taketo Tanikawa 等人:“心力衰竭中 cAMP 依赖性药物保留正向松弛的机制”美国生理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masafumi Yano: "Alterne storkinometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca^<2+> leak through ryanodine receptor in heart failure"Circulation. 102. 2131-2136 (2000)
Masafumi Yano:“FKBP12.6 与兰尼碱受体的交替斯托金测量法作为心力衰竭中通过兰尼碱受体异常 Ca^2 渗漏的原因”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YANO Masafumi其他文献

Real-time Control of Bipedal Movement based on Basal ganglia and Brainstem Systems
基于基底神经节和脑干系统的双足运动实时控制

YANO Masafumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YANO Masafumi', 18)}}的其他基金

Comprehensive treatment of heart failure, cardiac hypertrophy, and arrhythmia by controlling ryanodine receptor bound calmodulin
通过控制兰尼碱受体结合钙调蛋白综合治疗心力衰竭、心脏肥大和心律失常
  • 批准号:
    17H04178
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
An attempt to regress cardiac hypertrophy by cardiomyocyte intracellular calmodulin control
通过心肌细胞内钙调蛋白控制来逆转心脏肥大的尝试
  • 批准号:
    16K15443
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
New molecular targeting therapy for regression of cardiac hypertrophy by inhibiting abnormal Ca2+ leak through RyR2 in hypertrophic cardiomyopathy
通过 RyR2 抑制异常 Ca2 渗漏来消退肥厚型心肌病的新型分子靶向治疗
  • 批准号:
    26670404
  • 财政年份:
    2014
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Comprehensive strategy of heart failure, cardiac hypertrophy and lethal arrhythmia via stabilizing the stricture of ryanodine receptor
通过稳定兰尼碱受体狭窄治疗心力衰竭、心肌肥厚和致死性心律失常的综合策略
  • 批准号:
    26293189
  • 财政年份:
    2014
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of comprehensive treatment of heart failure, hypertrophy, and arrhythmia by regulating intracellular Ca
调节细胞内Ca综合治疗心力衰竭、肥厚、心律失常的进展
  • 批准号:
    23390215
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of therapeutic therapy for regression of cardiac hypertrophy in hypertrophic cardiomyopathy
肥厚型心肌病心肌肥厚消退治疗方法的开发
  • 批准号:
    22659154
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of new therapy for heart failure and arrhythmia by correction of signal transduction within cardiac ryanodine receptor
通过校正心脏兰尼碱受体内的信号转导开发心力衰竭和心律失常的新疗法
  • 批准号:
    20390226
  • 财政年份:
    2008
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of molecular targeting therapy for duonic heart failure bystabilizmgryanodine receptor
稳定麦草碱受体治疗双元心力衰竭分子靶向治疗的建立
  • 批准号:
    18390234
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Computational study on acoustic-image perception of object-shape from single-emission echo in bats
蝙蝠单次发射回声物体形状声像感知的计算研究
  • 批准号:
    17500190
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research in the inhibitory effect of sarcoplasmic reticulum Ca release channel stabilizer on the development of heart failure
肌浆网钙释放通道稳定剂抑制心力衰竭发展的研究
  • 批准号:
    13670717
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Critical Sorting Steps and Pathways in the Trafficking of Cardiac Sarcoplasmic Reticulum Proteins
心脏肌浆网蛋白运输的关键分选步骤和途径
  • 批准号:
    10719667
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Development of a method to inhibit muscle atrophy by targeting direct sarcoplasmic reticulum Ca2+ reuptake mechanism activation by drugs.
开发一种通过药物直接激活肌浆网 Ca2 再摄取机制来抑制肌肉萎缩的方法。
  • 批准号:
    23K08684
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glycogen synthase kinase-3 (GSK3) Inhibition and sarcoplasmic reticulum Ca2+ ATPase (SERCA) Function in Desmoglein-2 (Dsg2)-Mutant Mice
Desmoglein-2 (Dsg2) 突变小鼠中的糖原合酶激酶 3 (GSK3) 抑制和肌浆网 Ca2 ATP 酶 (SERCA) 功能
  • 批准号:
    566783-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Canadian Graduate Scholarships Foreign Study Supplements
Exploration of uncoupling mode of sarcoplasmic reticulum Ca2+ pump
肌浆网Ca2泵解偶联模式的探索
  • 批准号:
    21K06058
  • 财政年份:
    2021
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sarcoplasmic reticulum and contraction
肌浆网和收缩
  • 批准号:
    20K11306
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sarcoplasmic reticulum-mitochondrial functional interactions in muscle
肌肉中肌浆网-线粒体功能相互作用
  • 批准号:
    DP200100435
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Discovery Projects
Ingestion of nitric oxide donor could alleviate the decline of sarcoplasmic reticulum functions following eccentric contraction.
摄入一氧化氮供体可以缓解离心收缩后肌浆网功能的下降。
  • 批准号:
    18K10817
  • 财政年份:
    2018
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Formation and maintenance of the muscle sarcoplasmic reticulum
肌肉肌浆网的形成和维持
  • 批准号:
    526157-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 2.3万
  • 项目类别:
    University Undergraduate Student Research Awards
Effects of lipid envionment on the functions of sarcoplasmic reticulum calcium pump
脂质环境对肌浆网钙泵功能的影响
  • 批准号:
    18K06105
  • 财政年份:
    2018
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Energy coupling in Sarcoplasmic Reticulum Ca pump; mechanism of transmitting structural changes between catalytic and transport sites
肌浆网钙泵的能量耦合;
  • 批准号:
    17K07297
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了